Product Information
IBUPROFEN 100 MG/5 ML SUSP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0438 per ML under NDC 45802095226. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
100 mg/5mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802095226
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA076925On Market Since
12/8/2004
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 100 MG/5 ML SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0438 per ML |
|---|---|
| All-time high | $0.0532 (Jun 10, 2015) |
| All-time low | $0.0290 (Jun 22, 2022) |
| 52-week high | $0.0438 |
| 52-week low | $0.0386 |
| Median price | $0.0411 |
| Average price | $0.0416 |
| Largest weekly change | +46.4% (Jul 20, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 100 MG/5 ML SUSP, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0438 per ML (NDC 45802095226), effective Jun 24, 2026.
How has the price of IBUPROFEN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 100 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has ranged from a low of $0.0290 (Jun 22, 2022) to a high of $0.0532 (Jun 10, 2015), with a median of $0.0411 per ML.
Are there cheaper alternatives to IBUPROFEN 100 MG/5 ML SUSP?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 45% below IBUPROFEN 100 MG/5 ML SUSP.
Who manufactures IBUPROFEN 100 MG/5 ML SUSP?
IBUPROFEN 100 MG/5 ML SUSP (NDC 45802095226) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification